In an initial investigation using dual luciferase reporter gene assays, it was confirmed that miR-330-3p directly targets CELF1,resulting in the downregulation of CELF1 expression and subsequently inhibiting the proliferation and migration of glioma cells [68]. The gene discussed is CELF1; the disease is central nervous system cancer.